$TXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 10x Genomics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in 10x Genomics, Inc.. Get notifications about new insider transactions in 10x Genomics, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 178,584 | 0 | 178,584 | 0 to 178.6 K |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 700,000 | 0 | 869,802 | 1.6 M to 869.8 K (-44.59 %) |
Apr 23 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | A | 74.58 | 235,733 | 17,580,967 | 235,733 | |
Apr 23 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | A | 74.58 | 90,667 | 6,761,945 | 90,667 | |
Apr 23 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | A | 74.58 | 136,000 | 10,142,880 | 136,000 | |
Apr 23 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | A | 74.58 | 90,667 | 6,761,945 | 90,667 | |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 4,653,528 | |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,500,000 | 0 | 1,500,000 | 0 to 1.5 M |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 109,849 | 0 | 235,125 | 125.3 K to 235.1 K (+87.69 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 21,686 | 0 | 0 | 21.7 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 21,686 | 0 | 21,686 | 0 to 21.7 K |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 201,115 | 0 | 0 | 201.1 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 201,115 | 0 | 201,115 | 0 to 201.1 K |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 433,725 | 0 | 0 | 433.7 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 788,317 | 0 | 1,569,802 | 2.4 M to 1.6 M (-33.43 %) |
Apr 07 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 4,167 | 4,459 | 16,667 | |
Apr 07 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 4,167 | 4,459 | 16,667 | |
Apr 07 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 4,167 | 4,459 | 954,681 | 950.5 K to 954.7 K (+0.44 %) |
Apr 07 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 4,167 | 4,459 | 954,681 | 950.5 K to 954.7 K (+0.44 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 580,000 | |
Apr 03 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 59.82 | 200 | 11,964 | 0 | 200 to 0 (-100.00 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 58.32 | 5,110 | 298,025 | 200 | 5.3 K to 200 (-96.23 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 57.76 | 4,690 | 270,889 | 5,310 | 10 K to 5.3 K (-46.90 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,000 | 0 to 10 K |
Apr 03 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 315,000 | |
Apr 03 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 59.71 | 2,300 | 137,328 | 67,500 | 69.8 K to 67.5 K (-3.30 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 58.37 | 13,207 | 770,848 | 69,800 | 83 K to 69.8 K (-15.91 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 57.74 | 18,243 | 1,053,272 | 83,007 | 101.3 K to 83 K (-18.02 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 766,000 | |
Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 59.62 | 400 | 23,848 | 0 | 400 to 0 (-100.00 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 58.33 | 7,789 | 454,318 | 400 | 8.2 K to 400 (-95.12 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 57.75 | 8,811 | 508,840 | 8,189 | 17 K to 8.2 K (-51.83 %) |
Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
Mar 27 2020 | TXG | 10x Genomics, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 61.04 | 10,330 | 630,543 | 10,330 | |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 2,170,619 | 0 | 3,430,198 | |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 2,170,619 | 0 | 2,358,119 | 187.5 K to 2.4 M (+1,157.66 %) |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 2,170,619 | 0 | 3,430,198 | |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 2,170,619 | 0 | 2,358,119 | 187.5 K to 2.4 M (+1,157.66 %) |
Mar 25 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 12,500 | 13,375 | 20,834 | |
Mar 25 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 12,500 | 13,375 | 950,514 | 938 K to 950.5 K (+1.33 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 683,725 | 0 | 6,153,528 | |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,447,079 | 0 | 5,600,817 | |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 125,276 | 0 | 125,276 | 0 to 125.3 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 241,619 | 0 | 0 | 241.6 K to 0 (-100.00 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 241,619 | 0 | 241,619 | 0 to 241.6 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 947,079 | 0 | 187,500 | 1.1 M to 187.5 K (-83.47 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 59.00 | 250,000 | 14,750,000 | 433,725 | 683.7 K to 433.7 K (-36.56 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 59.00 | 500,000 | 29,500,000 | 1,134,579 | 1.6 M to 1.1 M (-30.59 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 683,725 | 0 | 683,725 | 0 to 683.7 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,447,079 | 0 | 1,634,579 | 187.5 K to 1.6 M (+771.78 %) |
Mar 18 2020 | TXG | 10x Genomics, Inc. | SOFTBANK VISION FUND (AIV M2) ... | 10% Owner | Option Exercise | C | 0.00 | 3,836,232 | 0 | 0 | |
Mar 18 2020 | TXG | 10x Genomics, Inc. | SOFTBANK VISION FUND (AIV M2) ... | 10% Owner | Option Exercise | C | 0.00 | 1,044,932 | 0 | 0 | |
Mar 18 2020 | TXG | 10x Genomics, Inc. | SOFTBANK VISION FUND (AIV M2) ... | 10% Owner | Option Exercise | C | 0.00 | 2,791,300 | 0 | 0 | |
Mar 18 2020 | TXG | 10x Genomics, Inc. | SOFTBANK VISION FUND (AIV M2) ... | 10% Owner | Option Exercise | C | 0.00 | 3,836,232 | 0 | 3,836,232 | |
Mar 18 2020 | TXG | 10x Genomics, Inc. | SOFTBANK VISION FUND (AIV M2) ... | 10% Owner | Buy | C | 0.00 | 3,836,232 | 0 | 3,836,232 | 0 to 3.8 M |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 1,667 | 2,000 | 142,083 | |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 8,333 | 8,916 | 33,334 | |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 70.01 | 447 | 31,293 | 938,014 | 938.5 K to 938 K (-0.05 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 69.34 | 822 | 57,000 | 938,461 | 939.3 K to 938.5 K (-0.09 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 68.13 | 618 | 42,103 | 939,283 | 939.9 K to 939.3 K (-0.07 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 66.86 | 600 | 40,116 | 939,901 | 940.5 K to 939.9 K (-0.06 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 65.79 | 800 | 52,628 | 940,501 | 941.3 K to 940.5 K (-0.08 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 64.91 | 1,098 | 71,273 | 941,301 | 942.4 K to 941.3 K (-0.12 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 63.91 | 3,767 | 240,761 | 942,399 | 946.2 K to 942.4 K (-0.40 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 62.91 | 1,848 | 116,262 | 946,166 | 948 K to 946.2 K (-0.19 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 1,667 | 2,000 | 948,014 | 946.3 K to 948 K (+0.18 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 8,333 | 8,916 | 946,347 | 938 K to 946.3 K (+0.89 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 33,750 | 29,700 | 348,750 | |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 69.84 | 3,845 | 268,533 | 67,500 | 71.3 K to 67.5 K (-5.39 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 69.20 | 3,099 | 214,449 | 71,345 | 74.4 K to 71.3 K (-4.16 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 67.96 | 1,300 | 88,344 | 74,444 | 75.7 K to 74.4 K (-1.72 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 66.73 | 2,000 | 133,464 | 75,744 | 77.7 K to 75.7 K (-2.57 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 65.74 | 3,816 | 250,848 | 77,744 | 81.6 K to 77.7 K (-4.68 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 64.85 | 6,200 | 402,064 | 81,560 | 87.8 K to 81.6 K (-7.06 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 63.78 | 8,702 | 555,051 | 87,760 | 96.5 K to 87.8 K (-9.02 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 62.88 | 4,788 | 301,060 | 96,462 | 101.3 K to 96.5 K (-4.73 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 33,750 | 29,700 | 101,250 | 67.5 K to 101.3 K (+50.00 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 590,000 | |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 69.68 | 1,225 | 85,359 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 68.26 | 900 | 61,432 | 1,225 | 2.1 K to 1.2 K (-42.35 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 66.75 | 600 | 40,047 | 2,125 | 2.7 K to 2.1 K (-22.02 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 65.72 | 700 | 46,002 | 2,725 | 3.4 K to 2.7 K (-20.44 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 64.58 | 1,940 | 125,280 | 3,425 | 5.4 K to 3.4 K (-36.16 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 63.65 | 2,835 | 180,439 | 5,365 | 8.2 K to 5.4 K (-34.57 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 62.77 | 1,800 | 112,993 | 8,200 | 10 K to 8.2 K (-18.00 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 10,000 | 0 to 10 K |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 783,000 | |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 70.35 | 41 | 2,884 | 0 | 41 to 0 (-100.00 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 69.10 | 5,800 | 400,777 | 41 | 5.8 K to 41 (-99.30 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 68.19 | 546 | 37,230 | 5,841 | 6.4 K to 5.8 K (-8.55 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 66.85 | 600 | 40,112 | 6,387 | 7 K to 6.4 K (-8.59 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 65.71 | 1,200 | 78,855 | 6,987 | 8.2 K to 7 K (-14.66 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 64.78 | 1,513 | 98,009 | 8,187 | 9.7 K to 8.2 K (-15.60 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 63.69 | 5,110 | 325,477 | 9,700 | 14.8 K to 9.7 K (-34.50 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 62.62 | 2,190 | 137,133 | 14,810 | 17 K to 14.8 K (-12.88 %) |
Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
Jan 14 2020 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | A | 1.20 | 150,000 | 180,000 | 150,000 | |
Jan 06 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Option Exercise | M | 0.88 | 67,500 | 59,400 | 382,500 | |
Jan 06 2020 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Buy | M | 0.88 | 67,500 | 59,400 | 67,500 | 0 to 67.5 K |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 3,037 | 34,865 | 127,563 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,208 | 26,248 | 182,292 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 11.48 | 3,037 | 34,865 | 127,563 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 4,167 | 5,000 | 112,500 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 5,208 | 26,248 | 182,292 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 6,250 | 7,500 | 143,750 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 4,167 | 5,000 | 112,500 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 4,167 | 4,459 | 41,667 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.20 | 6,250 | 7,500 | 143,750 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 3,037 | 34,865 | 938,014 | 935 K to 938 K (+0.32 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 1.07 | 4,167 | 4,459 | 41,667 | |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,208 | 26,248 | 934,977 | 929.8 K to 935 K (+0.56 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 11.48 | 3,037 | 34,865 | 938,014 | 935 K to 938 K (+0.32 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 4,167 | 5,000 | 929,769 | 925.6 K to 929.8 K (+0.45 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 5,208 | 26,248 | 934,977 | 929.8 K to 935 K (+0.56 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 6,250 | 7,500 | 925,602 | 919.4 K to 925.6 K (+0.68 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 4,167 | 5,000 | 929,769 | 925.6 K to 929.8 K (+0.45 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 4,167 | 4,459 | 919,352 | 915.2 K to 919.4 K (+0.46 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.20 | 6,250 | 7,500 | 925,602 | 919.4 K to 925.6 K (+0.68 %) |
Oct 15 2019 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 1.07 | 4,167 | 4,459 | 919,352 | 915.2 K to 919.4 K (+0.46 %) |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 653,082 | 0 | 8,675,167 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 653,082 | 0 | 0 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 1,004,868 | 0 | 8,022,085 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 1,004,868 | 0 | 0 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 2,476,963 | 0 | 7,017,217 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 2,476,963 | 0 | 0 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 3,749,767 | 0 | 4,540,254 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 3,749,767 | 0 | 0 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 790,487 | 0 | 790,487 | |
Sep 18 2019 | TXG | 10x Genomics, Inc. | Paladin Capital Management, LL ... | 10% Owner | Option Exercise | C | 0.00 | 790,487 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,091,816 | 0 | 11,091,816 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,272,171 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Venrock Associates VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,819,645 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 12,878,247 | 0 | 12,878,247 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 1,786,431 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 3,272,171 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 7,819,645 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | ROBERTS BRYAN E | Director | Buy | P | 39.00 | 300,000 | 11,700,000 | 300,000 | 0 to 300 K |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 6,837,253 | 0 | 6,837,253 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 7,047,896 | 0 | 7,047,896 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,324,195 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 5,513,058 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 558,260 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,002,166 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 5,487,470 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | P | 39.00 | 187,500 | 7,312,500 | 187,500 | 0 to 187.5 K |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | J | 1.16 | 200,000 | 232,000 | 200,000 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | J | 1.16 | 200,000 | 232,000 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Option Exercise | C | 0.00 | 49,634 | 0 | 49,634 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Option Exercise | C | 0.00 | 49,634 | 0 | 0 |